ACB
Aurora CannabisACB
ACB
About: Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
Employees: 1,130
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
106% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 18
67% more capital invested
Capital invested by funds: $20.6M [Q4 2024] → $34.5M (+$13.8M) [Q1 2025]
5.49% more ownership
Funds ownership: 8.84% [Q4 2024] → 14.33% (+5.49%) [Q1 2025]
3% less call options, than puts
Call options by funds: $4.19M | Put options by funds: $4.32M
6% less funds holding
Funds holding: 165 [Q4 2024] → 155 (-10) [Q1 2025]
21% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 29
Research analyst outlook
We haven’t received any recent analyst ratings for ACB.
Financial journalist opinion
Based on 6 articles about ACB published over the past 30 days
Neutral
PRNewsWire
1 week ago
Aurora Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company Adds Two New Cultivars to Popular Brand Portfolio in the Australian Market EDMONTON, AB , June 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has expanded their popular IndiMed brand with the launch of IndiMed TEMPO 22, available through the company's subsidiary, MedReleaf Australia. With the same consistent quality and reliable supply, this new 22% THC potency creates a greater range of treatment options available to prescribers.
Neutral
PRNewsWire
1 week ago
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information
NASDAQ | TSX: ACB EDMONTON, AB , June 3, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2025 on Wednesday, June 18, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m.
Positive
MarijuanaStocks
2 weeks ago
June 2025 Watchlist: Best Canadian Cannabis Stocks for Growth
As of June 2025, the U.S. cannabis industry continues its rapid expansion. Projections estimate the market will reach approximately $45 billion in revenue this year. This growth is fueled by increasing consumer demand, introducing innovative products, and technological advancements in cultivation and production. Despite federal prohibition, 24 states have legalized adult-use cannabis, and 39 states have legalized medical cannabis. However, federal legalization efforts face challenges. In May 2025, the 1st U.S. Circuit Court of Appeals upheld the federal ban on marijuana, rejecting a legal challenge by several Massachusetts cannabis businesses. This decision underscores the ongoing tension between federal law and evolving state cannabis regulations. Additionally, while the Biden administration has proposed reclassifying marijuana to a less restricted category, the outcome remains uncertain, especially under a new administration.
Positive
Zacks Investment Research
2 weeks ago
Aurora Cannabis Stock Rises 30% YTD: Time to Buy or Sell?
ACB's 30% YTD rally reflects Q3 strength, but flat EPS estimates and consumer weakness keep analysts cautious about long-term upside.
Neutral
PRNewsWire
2 weeks ago
Aurora to Participate in TD Cowen's 9th Annual Future of the Consumer Conference
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company to Discuss Key Trends, Market Opportunities and the Future of the Global Cannabis Industry EDMONTON, AB , May 27, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, will participate in TD Cowen's 9th Annual Future of the Consumer Conference in New York City, NY. Simona King, Chief Financial Officer at Aurora, will take part in a fireside chat and one-on-one meetings with investors on June 3, 2025, at 2:45pm EST.
Positive
Seeking Alpha
3 weeks ago
Aurora Cannabis: Underappreciated Turnaround
Aurora Cannabis remains a bullish opportunity due to its cheap valuation and an improving business model, despite recent stock weakness. International medical cannabis sales are growing, especially in Germany, but mixed global market dynamics and regulatory changes create volatility. Aurora's strong adjusted EBITDA, positive cash flow, and low debt position set the stage for potential upside if growth continues.
Positive
MarijuanaStocks
1 month ago
3 Marijuana Stocks For The Long Term Investing
Marijuana stocks hold lots of potential for home-run investments in the future. In 2018, most pot stocks saw their first wave of the green rush. Yet over the last several years, this has not been the case and things have changed drastically. Still, the way companies are keeping up with. Market demand profits and revenue are steadily rising. However, this success has played very little in how most marijuana stocks trade.
Neutral
PRNewsWire
1 month ago
Aurora Cannabis Announces the Completion of a Multimillion Dollar Investment and Renaming of B.C. Manufacturing Facility
NASDAQ | TSX: ACB Company's Long-Standing Investment in Operational Excellence Continues with Industry Leading Upgrades and Renaming the Facility to Aurora Alpine EDMONTON, AB , April 30, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the completion of a multi-year investment of $3 million in improvements to its manufacturing facility in Pemberton, British Columbia. These upgrades are a combination of Aurora's proprietary high-performing genetics and state-of-the-art engineering design which have resulted in optimal cultivation conditions, expanded output, and superior product quality.
Positive
MarijuanaStocks
1 month ago
3 Canadian Marijuana Stocks That Could See Big Future Gains
When it comes to finding marijuana stocks to buy a happy medium or silver lining at this time is tough to do. Not becuase the low share prices from some of the top-performing companies dont look appetizing. It is more due to the consistent falls in the sector no real upward push. Even as the cannabis industry as a whole is thriving and showing great long-term success.
Neutral
PRNewsWire
2 months ago
Aurora Cannabis Introduces the Company's First Inhalable Resin Cartridges for Patients in the United Kingdom
NASDAQ | TSX: ACB Canada's Leading Medical Cannabis Company Expands Patient Offering with Innovative Dosage Solution EDMONTON, AB , April 15, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the availability of medical cannabis concentrates to patients in the United Kingdom (UK). This launch marks the company's meaningful step in offering its proprietary cultivar-specific inhalable cannabis extracts in the UK market.
Charts implemented using Lightweight Charts™